Detalhe da pesquisa
1.
Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source.
N Engl J Med
; 378(23): 2191-2201, 2018 Jun 07.
Artigo
Inglês
| MEDLINE | ID: mdl-29766772
2.
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the prevention of venous thromboembolism.
J Thromb Thrombolysis
; 50(1): 12-19, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32323190
3.
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in the treatment of venous thromboembolism.
J Thromb Thrombolysis
; 50(1): 1-11, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32323191
4.
Associations between model-predicted rivaroxaban exposure and patient characteristics and efficacy and safety outcomes in patients with non-valvular atrial fibrillation.
J Thromb Thrombolysis
; 50(1): 20-29, 2020 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-32323192
5.
Predictors of Recurrent Ischemic Stroke in Patients with Embolic Strokes of Undetermined Source and Effects of Rivaroxaban Versus Aspirin According to Risk Status: The NAVIGATE ESUS Trial.
J Stroke Cerebrovasc Dis
; 28(8): 2273-2279, 2019 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-31160218
6.
Characterization of Patients with Embolic Strokes of Undetermined Source in the NAVIGATE ESUS Randomized Trial.
J Stroke Cerebrovasc Dis
; 27(6): 1673-1682, 2018 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-29525076
7.
The potent M1 receptor allosteric agonist GSK1034702 improves episodic memory in humans in the nicotine abstinence model of cognitive dysfunction.
Int J Neuropsychopharmacol
; 16(4): 721-31, 2013 May.
Artigo
Inglês
| MEDLINE | ID: mdl-22932339
8.
Giving monoclonal antibodies to healthy volunteers in phase 1 trials: is it safe?
Br J Clin Pharmacol
; 76(2): 164-72, 2013 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-23438102
9.
Exosite 1 thrombin inhibition with JNJ-64179375 inhibits thrombus formation in a human translational model of thrombosis.
Cardiovasc Res
; 115(3): 669-677, 2019 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30184110
10.
Randomized phase 2 trial comparing JNJ-9375, a thrombin-directed antibody, with apixaban for prevention of venous thrombosis.
J Thromb Haemost
; 17(12): 2081-2088, 2019 12.
Artigo
Inglês
| MEDLINE | ID: mdl-31529590
11.
Influence of model-predicted rivaroxaban exposure and patient characteristics on efficacy and safety outcomes in patients with acute coronary syndrome.
Ther Adv Cardiovasc Dis
; 13: 1753944719863641, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31364490
12.
Comparison of ximelagatran with warfarin for the prevention of venous thromboembolism after total knee replacement.
N Engl J Med
; 349(18): 1703-12, 2003 Oct 30.
Artigo
Inglês
| MEDLINE | ID: mdl-14585938
13.
A Cross-Study Analysis Evaluating the Effects of Food on the Pharmacokinetics of Rivaroxaban in Clinical Studies.
J Clin Pharmacol
; 57(12): 1607-1615, 2017 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-28679020
14.
Benefits and Challenges of Teaching Nursing Online: Exploring Perspectives of Different Stakeholders.
J Nurs Educ
; 55(8): 433-40, 2016 Aug 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27459429
15.
Pharmacokinetics and Safety of Single Intravenous Doses of JNJ-54452840, an Anti-ß1-Adrenergic Receptor Antibody Cyclopeptide, in Healthy Male Japanese and Caucasian Participants.
Clin Pharmacokinet
; 55(2): 225-36, 2016 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-26242382
16.
The MARINER trial of rivaroxaban after hospital discharge for medical patients at high risk of VTE. Design, rationale, and clinical implications.
Thromb Haemost
; 115(6): 1240-8, 2016 06 02.
Artigo
Inglês
| MEDLINE | ID: mdl-26842902
17.
Rivaroxaban for secondary stroke prevention in patients with embolic strokes of undetermined source: Design of the NAVIGATE ESUS randomized trial.
Eur Stroke J
; 1(3): 146-154, 2016 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-31008276
18.
Ximelagatran versus warfarin for the prevention of venous thromboembolism after total knee arthroplasty. A randomized, double-blind trial.
Ann Intern Med
; 137(8): 648-55, 2002 Oct 15.
Artigo
Inglês
| MEDLINE | ID: mdl-12379064
19.
No influence of obesity on the pharmacokinetics and pharmacodynamics of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran.
Clin Pharmacokinet
; 42(5): 485-92, 2003.
Artigo
Inglês
| MEDLINE | ID: mdl-12739986
20.
Peripheral and gasserian ganglion-level procedures for the treatment of trigeminal neuralgia.
Clin J Pain
; 18(1): 28-34, 2002.
Artigo
Inglês
| MEDLINE | ID: mdl-11803300